Tan Henkie P, Madeb Ralph, Kovach Stephen J, Orloff Mark, Mieles Luis, Johnson Lesley A, Bozorgzadeh Adel, Marcos Amadeo
Thomas E. Starzl Transplant Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Transplantation. 2003 Oct 15;76(7):1085-8. doi: 10.1097/01.TP.0000085652.47821.8A.
Hypophosphatemia appears to be a universal event after right hepatic lobectomy for live-donor adult liver transplantation according to one report. Because hypophosphatemia appears to contribute to increased postoperative complications, routine hyperalimentation with supratherapeutic levels of phosphorus was advocated.
From July 2000 to May 2002, we performed 95 right-lobe living-donor hepatectomies for 95 adult liver-transplant recipients, the largest single institutional experience. We reviewed our data that were collected prospectively.
We did not find profound hypophosphatemia (<1.0 mg/dL) to be prevalent in our donors. At least six (6.3%) donors did not have postoperative hypophosphatemia. In addition, there appears to be no increased morbidity related to hypophosphatemia when aggressively corrected with intravenous or oral phosphates in our group of donors that underwent right-lobe hepatectomies.
We, therefore, cannot endorse the routine administration of hyperalimentation with supratherapeutic phosphorus because of its potential morbidity.
根据一份报告,低磷血症似乎是活体供体成人肝移植右半肝切除术后的普遍现象。由于低磷血症似乎会导致术后并发症增加,因此有人主张采用超治疗剂量的磷进行常规肠外营养。
2000年7月至2002年5月,我们为95例成人肝移植受者实施了95例右半肝活体供肝切除术,这是最大的单机构经验。我们回顾了前瞻性收集的数据。
我们发现供体中并未普遍存在严重低磷血症(<1.0mg/dL)。至少有6例(6.3%)供体术后没有出现低磷血症。此外,在我们接受右半肝切除术的供体组中,积极静脉或口服补充磷酸盐纠正低磷血症后,似乎并未增加发病率。
因此,由于其潜在的发病率,我们不能支持常规给予超治疗剂量的磷进行肠外营养。